Infectious Agents and Cancer is affiliated with the African Organisation for Research & Training In Cancer (AORTIC)
Articles
Page 15 of 22
-
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P49
-
Dysregulated cytokine and growth factor expression in OSSN HIV-1 patients from Botswana with multiple infections
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P46 -
Pathogen discovery in AIDS-related lymphoma by high-throughput sequencing
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P45 -
Viral FLICE inhibitory protein of Rhesus monkey rhadinovirus inhibits apoptosis by enhancing autophagosome formation
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P44 -
The prevalence of HIV-1 DNA in AIDS-related lymphoma and Kaposi Sarcoma throughout the AIDS epidemic
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P43 -
Signal transducer and activator of transcription 3 (STAT3) controls susceptibility to Epstein-Barr virus reactivation in B cells
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P42 -
KSHV induces rapid release of angiopoietin-2 from endothelial cells to promote angiogenesis and inflammation
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P41 -
Kaposi sarcoma associated herpesvirus infection of primary human endothelial cells activates the proto-oncogene STAT3
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P38 -
Induction of KSHV latency-associated nuclear antigen (LANA) by hypoxia and hypoxia-inducible factors (HIF)
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P37 -
Human herpesvirus 8 replicates in primary B lymphocytes and induces polyfunctional cytokine and chemokine responses
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P36 -
HPV+ cancer cell lactate production attenuates immune response during treatment: lactate production inhibition leads to improved long-term cures
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P35 -
ER stress activates lytic gene expression in KSHV-associated tumor cell lines
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P33 -
Epstein-Barr virus induces adhesion molecule CD226 (DNAM-1) expression during primary B cell transformation into lymphoblastoid cell lines
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P31 -
Development of multiplex serological assays to detect oncoviral infections
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P30 -
CpG methylation as a tool to characterize cell-free Epstein-Barr virus DNA
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P29 -
A core laboratory for the generation of quality-controlled g-herpesvirus bacmids: generation of KSHV microRNA mutants
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P27 -
Hodgkin’s lymphoma characteristics in HIV-infected and uninfected patients at an urban hospital in the late combined antiretroviral era
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P26 -
Hepatobiliary cancers in persons With HIV/AIDS in the United States
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O25 -
Ultraviolet radiation exposure and HIV-associated non-Hodgkin lymphoma risk
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P25 -
Identifying predictors of increased quantities of human Herpesvirus 8 DNA detection at oropharyngeal and plasma sites among Ugandan adults with and without HIV and Kaposi Sarcoma
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O23 -
Sarcomas other than Kaposi's sarcoma in immunodeficiency
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P23 -
Decline in EBV-Specific IFN T cell responses in Kenyan infants from a malaria holoendemic region of Kenya
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O22 -
R-CHOP versus CHOP in HIV-associated lymphoma: a meta-analysis of prospective studies
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P22 -
Prevalence of HIV in Medicare beneficiaries with lung cancer
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P21 -
Incidence of Kaposi Sarcoma in HIV-infected patients – a prospective multi-cohort study from Southern Africa
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O20 -
Multicentric Castleman’s disease in HIV/AIDS patients at an urban HIV clinic in Atlanta, Georgia, in the combined antiretroviral therapy era
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P20 -
Penile cancers without the AIDS epidemic in Cameroon
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P19 -
Risk factors for death and temporal trends in overall survival in patients with AIDS-associated primary central nervous system lymphoma (AIDS-PCNSL)
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O18 -
CD4 regulatory T cells Control CD8 T cell responses to human Herpesvirus 8 lytic and latency proteins
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O17 -
Malignancies in AIDS patients: the experience of a tertiary hospital in a high prevalence zone
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P17 -
Knowledge attitude and practice of malignancies among PLWHIV in Nigeria
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P16 -
HPV monitoring in kidney transplanted patients
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P15 -
Digital cervicography and cold coagulation for cervical cancer screening in Nigeria
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P14 -
Prevalence of cervical and anal warts among HIV patients on ARV Nigerian special treatment center
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O13 -
Human papillomavirus prevalence in invasive cervical carcinoma by HIV Status
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O12 -
HIV-associated non-Hodgkin's lymphoma-experience from a tertiary referral cancer center
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P12 -
Differential modulation of human beta-defensin-3 expression in human oral epithelial cells by HPV oncoproteins E6 and E7: potential implication in oral cancer
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O11 -
The impact of the HIV epidemic on U.S. anal cancer rates, 1980-2007
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O10 -
Gender differences in HIV-infected and HIV-uninfected patients with lung cancer
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P10 -
Determinants of mTOR inhibitor therapy in AIDS-associated malignancies
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O9 -
Herpesviruses control the DNA damage response through TIP60
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O8 -
Efficacy of a latency- and productive infection-deficient Gammaherpesvirus as a vaccine strategy
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O7 -
KSHV infection of endothelial cells manipulates CXCR7-mediated signaling: implications for Kaposi’s Sarcoma progression and intervention
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O6 -
Anal HIV DNA is associated with high-risk HPV genotypes in anal cytology specimens obtained for anal neoplasia screening
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P4 -
Comprehensive analysis of the KSHV MiRNA targetome by Ago-HITS-CLIP
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O4 -
Creating a nationwide cancer registration system to support AIDS-cancer match studies in Nigeria
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P3 -
EBV-regulated global changes in mRNA isoform usage
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O3 -
Changes in incidence and prognosis of malignancies in children with HIV
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P2 -
Analysis of the miRNA targetome in EBV-infected B cells
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O2 -
AIDS-related lymphoma at the University of calabar teaching hospital (Nigeria): a seven year review
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P1
-
Affiliated with
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Editors' Profile
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
2022 Citation Impact
3.7 - 2-year Impact Factor
3.8 - 5-year Impact Factor
1.040 - SNIP (Source Normalized Impact per Paper)
0.583 - SJR (SCImago Journal Rank)2023 Speed
14 days submission to first editorial decision for all manuscripts (Median)
112 days submission to accept (Median)2023 Usage
687,750 downloads
813 Altmetric mentions
What is trending?
Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.